SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-074001
Filing Date
2014-10-27
Accepted
2014-10-27 16:15:37
Documents
16
Period of Report
2014-10-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-23067_18k.htm 8-K 24693
2 EX-99.1 a14-23067_1ex99d1.htm EX-99.1 22803
3 GRAPHIC g230671mmi001.gif GRAPHIC 36306
4 GRAPHIC g230671mmi002.gif GRAPHIC 36513
5 GRAPHIC g230671mmi003.gif GRAPHIC 26659
6 GRAPHIC g230671mmi004.gif GRAPHIC 37971
7 GRAPHIC g230671mmi005.gif GRAPHIC 35999
8 GRAPHIC g230671mmi006.gif GRAPHIC 61871
9 GRAPHIC g230671mmi007.gif GRAPHIC 69885
10 GRAPHIC g230671mmi008.gif GRAPHIC 43335
11 GRAPHIC g230671mmi009.gif GRAPHIC 37986
12 GRAPHIC g230671mmi010.gif GRAPHIC 54874
13 GRAPHIC g230671mmi011.gif GRAPHIC 50783
14 GRAPHIC g230671mmi012.gif GRAPHIC 67779
15 GRAPHIC g230671mmi013.gif GRAPHIC 47169
16 GRAPHIC g230671mmi014.gif GRAPHIC 39990
  Complete submission text file 0001104659-14-074001.txt   942326
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 141174710
SIC: 2834 Pharmaceutical Preparations